Condition
Agitation clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Agitation clinical trials that are recruiting, at sites in 29 countries (most in United States (3), Germany (2), France (2)). By phase: Phase 3 (2), Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 29Countries
Newest Agitation clinical trials
All recruiting trials (8)
-
PARO robotic seal to reduce agitation after visceral surgery
This trial tests whether interacting with PARO, a social robotic seal, reduces postoperative agitation in adults having elective visceral surgery.
-
Daily Screen Time and Postoperative Delirium in Children (2–11) After Lower Abdominal Surgery
This study tests whether how much a child uses screens daily is linked to the child’s emergence delirium in the first 30 minutes after waking up from anesthesia.
-
Long-term KarXT plus KarX-EC treatment for agitation in Alzheimer’s disease
This will test whether taking KarXT together with KarX-EC reduces agitation and is safe long-term in people with Alzheimer’s disease who completed the earlier parent studies.
-
BMS-986368 for treating agitation in Alzheimer's disease
This will test whether BMS-986368 can reduce agitation in people with biomarker-confirmed Alzheimer's disease.
-
Improving treatment for acute agitation in psychiatric patients
This study is testing two new medications to see if they can help calm down psychiatric patients who are very agitated when usual methods don't work.
-
Monitoring brain activity in ICU patients with sedation and delirium
This study is testing a new brain monitoring device to see if it can help doctors better understand sedation and delirium in patients who are intubated and sedated in the ICU.
-
Detecting risky behaviors in agitated, bedridden neurosurgery patients
This project will try to detect and record risky behaviors in hospitalized bedridden patients who are agitated or confused so clinicians can understand how often and what types occur.
-
Using nabilone to treat agitation in Alzheimer's patients
This study is testing if nabilone can help reduce agitation in people with Alzheimer's disease to improve their overall well-being.
Related topics
Quick answers
How many Agitation clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 29 countries. The most sites are in United States (3 trials), Germany (2 trials), France (2 trials), Argentina (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.